The reaction of malondialdehyde with lens proteins and the protective effect of aspirin
- 1 October 1993
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1158 (2) , 107-112
- https://doi.org/10.1016/0304-4165(93)90003-q
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Prevention of cataract in diabetic rats by aspirin, paracetamol (acetaminophen) and ibuprofenExperimental Eye Research, 1992
- Protection against cataract by aspirin, paracetamol and ibuprofenActa Ophthalmologica, 1989
- Lipid peroxidation and human cataractogenesis in diabetes and severe myopiaExperimental Eye Research, 1989
- The non-enzymic glycosylation of bovine lens proteins by glucosamine and its inhibition by aspirin, ibuprofen and glutathioneExperimental Eye Research, 1989
- Lens opacity induced by lipid peroxidation products as a model of cataract associated with retinal diseaseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Dimer and trimer of malonaldehydeJournal of the Chemical Society, Perkin Transactions 1, 1989
- DO ASPIRIN-LIKE ANALGESICS PROTECT AGAINST CATARACT?: A Case-control StudyThe Lancet, 1986
- Aspirin prevents carbamylation of soluble lens proteins and prevents cyanate-induced phase separation opacities in vitro: A possible mechanism by which aspirin could prevent cataractExperimental Eye Research, 1985
- Synthesis and characterization of the fluorescent products derived from malonaldehyde and amino acidsBiochemistry, 1969
- CHARACTERIZATION OF THE RED PIGMENT FORMED IN THE 2‐THIOBARBITURIC ACID DETERMINATION OF OXIDATIVE RANCIDITYa,bJournal of Food Science, 1958